ASM and TIGR team up on microbial genomes conference

The American Society for Microbiology (ASM) and The Institute for Genomic Research (TIGR) will cosponsor the Conference on Microbial Genomes, to be held January 28-31, 2001 at the Hyatt Regency Hotel in Monterey, California.

When scientists complete the sequencing of the human genome in the next year or so, their work will have just begun. They will be faced with an enormous database listing genetic sequences that must be deciphered to have any practical use. Fortunately, bacteria often contain genes similar to those found in humans, and scientists may already know what these genes do. The smaller, less complex genomes of microbes will serve as the genomic equivalent of the Rosetta Stone to help interpret and understand the human genome.

Proteomics, the study of the expression and interaction of proteins, has taken off in the wake of microbial genome sequencing. The synergy between between these two fields will quickly shed light on how some microbes cause disease and help identify targets for new drugs. Microbial genomes will also offer important information for developing new DNA-based vaccines, gene therapies and new biodegradable chemicals for industrial processes.

Session topics include genome projects, evolution, functional genomics and bioinformatics. More detailed information, including a preliminary program and general registration information can be found online at http://www.asmusa.org/mtgsrc/MicrobialGenomesg.htm. A limited number of complimentary registrations are available to members of the press. Pre-registration is required for the media. If you are interested in attending as press please contact Jim Sliwa, ASM Office of Communications, jsliwa@asmusa.org, or by phone at (202) 942-9297.


Contact: Jim Sliwa
American Society for Microbiology

Page: 1

Related biology news :

1. Study suggests insect-derived antimicrobial peptides could be used as drug-delivery vehicles
2. Protease-inhibitor cocktail protects, increases anti-microbial action of promising new peptide
3. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
4. Plant pathologists express need for plant pathology-related microbial culture resources
5. TIGR and NIAID sign $65 million microbial sequencing contract
6. Phages point the way to novel targets for antimicrobial drug discovery
7. New research challenges prevailing theory of microbial biodiversity
8. Yeast, wormwood & bacterial genes combine in microbial factory to make antimalarial drug
9. Brookhaven Lab & Battelle collaborate on research that may lead to novel anti-microbial drugs
10. Green tea boosts antimicrobial properties of toothpaste
11. JGI and Diversa Corp. announce large-scale microbial sequencing collaboration

Post Your Comments:

(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
Cached News: